OncoBeta® GmbH with its headquarters located at the Garching Technology and Founders Center GATE near Munich, is a privately held medical device company, specializing in the development and commercialization of state-of-the-art, innovative therapies utilizing epidermal radioisotope applications.
Their aim is to continuously improve the therapy of non-melanoma skin cancer (basal cell carcinoma- and squamous cell carcinoma of the skin).
Further information and contact: www.oncobeta.com.
